Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 3

Results: 13

Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safety.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 305, doi. 10.1111/ejh.13808

By:

Patrick, Hannah;
Ramasamy, Karthik;
Rashid, Sabia

Publication type:

Article

Herpes zoster prophylaxis with low‐dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 298, doi. 10.1111/ejh.13810

By:

Abbasov, Emin;
Metzner, Bernd;
Müller, Thomas H.;
Casper, Jochen;
Kimmich, Christoph;
Petershofen, Eduard K.;
Renzelmann, Andrea;
Rosien, Bernd;
Thole, Ruth;
Voß, Andreas;
Köhne, Claus Henning

Publication type:

Article

Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: An Italian multicentre study.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 289, doi. 10.1111/ejh.13809

By:

Pistoia, Laura;
Meloni, Antonella;
Allò, Massimo;
Spasiano, Anna;
Messina, Giuseppe;
Sorrentino, Francesco;
Gamberini, Maria Rita;
Ermini, Angela;
Renne, Stefania;
Fina, Priscilla;
Peritore, Giuseppe;
Positano, Vincenzo;
Pepe, Alessia;
Cademartiri, Filippo

Publication type:

Article

Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 282, doi. 10.1111/ejh.13807

By:

Ionescu, Filip;
Anusim, Nwabundo;
Zimmer, Markie;
Jaiyesimi, Ishmael

Publication type:

Article

Cell‐free DNA levels are increased in acute graft‐versus‐host disease.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 271, doi. 10.1111/ejh.13806

By:

Kroeze, Anna;
Cornelissen, Anne S.;
Pascutti, M. Fernanda;
Verheij, Myrddin;
Bulder, Ingrid;
Klarenbeek, Sjoerd;
Ait Soussan, Aicha;
Hazenberg, Mette D.;
Nur, Erfan;
van der Schoot, C. Ellen;
Voermans, Carlijn;
Zeerleder, Sacha S.

Publication type:

Article

Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia Group

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 257, doi. 10.1111/ejh.13805

By:

Kolonen, Aarne;
Sinisalo, Marjatta;
Huhtala, Heini;
Rimpiläinen, Johanna;
Rintala, Hannele;
Sankelo, Marja;
Koivunen, Elli;
Silvennoinen, Raija;
Räty, Riikka;
Ruutu, Tapani;
Volin, Liisa;
Porkka, Kimmo;
Jantunen, Esa;
Nousiainen, Tapio;
Kuittinen, Taru;
Penttilä, Karri;
Pyörälä, Marja;
Säily, Marjaana;
Koistinen, Pirjo;
Kauppila, Marjut

Publication type:

Article

Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control study.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 250, doi. 10.1111/ejh.13804

By:

Rago, Angela;
Annibali, Ombretta;
Tomarchio, Valeria;
Coppetelli, Ugo;
Fazio, Francesca;
Cupelli, Luca;
Fiorini, Alessia;
Piciocchi, Alfonso;
Tafuri, Agostino;
Caravita di Toritto, Tommaso

Publication type:

Article

Incidence of adult primary immune thrombocytopenia in England—An update.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 238, doi. 10.1111/ejh.13803

By:

Doobaree, Indraraj Umesh;
Conway, Katherine;
Miah, Haroon;
Miah, Atiqa;
Makris, Michael;
Hill, Quentin;
Cooper, Nicola;
Bradbury, Charlotte;
Newland, Adrian;
Provan, Drew;
McDonald, Vickie

Publication type:

Article

Development and validation of the sickle cell stress scale‐adult.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 215, doi. 10.1111/ejh.13789

By:

Smith, Wally R.;
McClish, Donna K.;
Bovbjerg, Viktor E.;
Singh, Harjot K.

Publication type:

Article

Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 205, doi. 10.1111/ejh.13783

By:

Kulasekararaj, Austin G.;
Griffin, Morag;
Langemeijer, Saskia;
Usuki, Kensuke;
Kulagin, Alexander;
Ogawa, Masayo;
Yu, Ji;
Mujeebuddin, Arshad;
Nishimura, Jun‐ichi;
Lee, Jong Wook;
Peffault de Latour, Régis;
Latypova, Aigul;
Barcellini, Wilma;
Barraco, Fiorenza;
Beam, Donald;
Bettelheim, Peter;
Borisenkova, Elena;
Brodsky, Andres;
Carnley, Benedict;
Cermak, Jaroslav

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2022, v. 109, n. 3, p. 195, doi. 10.1111/ejh.13659
Publication type:: Article

Validation of patient‐reported vaso‐occlusive crisis day as an endpoint in sickle cell disease studies.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 226, doi. 10.1111/ejh.13790

By:

Coyne, Karin S.;
Currie, Brooke M.;
Callaghan, Michael;
Wyrwich, Kathleen W.;
Pease, Sheryl;
Baker, Christine L.;
Arkin, Steven;
Pittman, Debra D.

Publication type:

Article

Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real‐world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry.

Published in:

European Journal of Haematology, 2022, v. 109, n. 3, p. 197, doi. 10.1111/ejh.13773

By:

Höchsmann, Britta;
de Fontbrune, Flore Sicre;
Lee, Jong Wook;
Kulagin, Alexander D.;
Hillmen, Peter;
Wilson, Amanda;
Marantz, Jing L.;
Schrezenmeier, Hubert

Publication type:

Article